AI Article Synopsis

  • A female patient experienced repeated venous thromboembolisms (VTEs) even while receiving appropriate anticoagulant treatment.
  • Various anticoagulants were tested, but each resulted in treatment failure.
  • After initiating dual anticoagulation with warfarin and apixaban, the patient did not have any further clotting issues, highlighting the potential benefits of dual therapy for those who do not respond to single-agent anticoagulants.

Article Abstract

We report the case of a female with recurrent venous thromboembolisms (VTEs) despite being appropriately anticoagulated. Different anticoagulants were trialed and all led to treatment failure. As a result, the patient was started on dual anticoagulation with warfarin and apixaban. There were no recurrences of clots while the patient was adherent to dual anticoagulation. This case report adds to current literature demonstrating the efficacy of dual anticoagulation in patients with recurrent VTE who fail single-agent therapy. It also demonstrates the need for additional studies that evaluate the utility of dual anticoagulants as a treatment modality for patients failing monotherapy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556604PMC
http://dx.doi.org/10.7759/cureus.29093DOI Listing

Publication Analysis

Top Keywords

dual anticoagulation
16
anticoagulation warfarin
8
warfarin apixaban
8
case report
8
dual
5
apixaban case
4
report report
4
report case
4
case female
4
female recurrent
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!